

Cover Story
FreeObituary
John Mark Cleland died peacefully on Feb. 7, 2022, in Indianapolis. Some people reading this headline will have little or no idea who John Cleland was. However, if you are a medical or urological oncologist, you should. John Cleland was the first man whose metastatic testicular cancer was cured with combination chemotherapy containing cisplatin.
Black History MonthCancer History ProjectFree
By Alexandria Carolan and Alice Tracey
In Brief


Clinical Roundup


Trending Stories
- Caught in the crossfire: The critical threats facing cancer centers, research, and patient care
- Backlog of work grows at NIH as staff members are being hounded to quit
- Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism
- In the Headlines: Could “flooding the zone” drown NIH and cancer centers?
- In the Headlines: What are Jay Bhattacharya’s plans for NIH?
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers